[1] Kotzin BL. Systemic lupus erythematosus.Cell, 1996, 85:303-306.
[2] Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25:1271-1277.
[3] Ishida H, Muchamuel T, Sakaguchi S, et al.Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med,1994, 179:305-310.
[4] Llorente L, Richaud-Patin Y, Garcia-Padilla C, et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum, 2000, 43:1790-1800.
[5] 张红娟,王宗发,彭学标,等.系统性红斑狼疮患者血清白介素10水平与外周血单一核细胞分泌白介素12水平的关系.中华皮肤科杂志,2001,34:287.
[6] 王美美,许桦,许晋.系统性红斑狼疮患者外周血单个核细胞分泌白细胞介素-10干扰素-γ水平的研究.中华风湿病学杂志,2002,6:28-30.
[7] Jones BM, Liu T, Wong RW. Reduced in vitro production of interferon-gamma, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10and tumour necrosis factor-alpha in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity. Autoimmunity, 1999, 31:117-124.
[8] Llorente L, Richaud-Patin Y, Couderc J, et al. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum,1997, 40:1429-1435. |
